» Articles » PMID: 15033168

Identification and Developmental Analysis of Genes Expressed by Dopaminergic Neurons of the Substantia Nigra Pars Compacta

Overview
Date 2004 Mar 23
PMID 15033168
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The hallmark of Parkinson's Disease is the degenerative loss of mesencephalic dopaminergic (mDA) neurons. Previous studies have shown that the homeobox transcription factors, engrailed-1 and -2, are essential for the survival of these cells. To identify genes downstream of engrailed-1 and -2, we performed a PCR-based differential display, comparing RNA from engrailed-1/2 double mutant and wild type ventral midbrain of different embryonic ages to adult olfactory bulb, a source of unrelated DA neurons. Here, we report the result of this experiment and describe the developmental expression pattern in the ventral midbrain of three of the isolated genes, HNF3alpha, synaptotagmin I, and Ebf3. Though not regulated by engrailed-1 and -2, the expression of all three genes is limited to mDA neurons and a few other brain areas. HNF3alpha appears in the precursors of mDA neurons at E9 and is expressed in the adult brain almost exclusively by this neuronal population. Synaptotagmin I is expressed from E14 into adulthood. Ebf3, in contrast, is transiently expressed during early postmitotic differentiation.

Citing Articles

Unveiling the prenatal features of HADDS: A case report and literature review.

Hu L, Li D, Zhen L, Wang Y Heliyon. 2025; 11(2):e41591.

PMID: 39911434 PMC: 11795036. DOI: 10.1016/j.heliyon.2024.e41591.


Genes critical for development and differentiation of dopaminergic neurons are downregulated in Parkinson's disease.

Verma A, Kommaddi R, Gnanabharathi B, Hirsch E, Ravindranath V J Neural Transm (Vienna). 2023; 130(4):495-512.

PMID: 36820885 DOI: 10.1007/s00702-023-02604-x.


Subregional differences in astrocytes underlie selective neurodegeneration or protection in Parkinson's disease models in culture.

Kostuk E, Cai J, Iacovitti L Glia. 2019; 67(8):1542-1557.

PMID: 31025779 PMC: 6594409. DOI: 10.1002/glia.23627.


Efficient treatment of Parkinson's disease using ultrasonography-guided rhFGF20 proteoliposomes.

Niu J, Xie J, Guo K, Zhang X, Xia F, Zhao X Drug Deliv. 2018; 25(1):1560-1569.

PMID: 30043675 PMC: 6060384. DOI: 10.1080/10717544.2018.1482972.


Regional microglia are transcriptionally distinct but similarly exacerbate neurodegeneration in a culture model of Parkinson's disease.

Kostuk E, Cai J, Iacovitti L J Neuroinflammation. 2018; 15(1):139.

PMID: 29751760 PMC: 5948771. DOI: 10.1186/s12974-018-1181-x.